News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Company News

Advanced Search
Show 5102550100 per page
More Company News
06/17/2021

By Victor Crawford, CEO of the Pharmaceutical Segment at Cardinal Health

06/17/2021

In response to Ohio Governor Mike DeWine's request that business leaders help increase vaccination rates, four Ohio Managed Care Organizations (MCOs) are partnering with Outcomes™ to leverage...

06/16/2021

By Steve Mason, CEO of the Medical Segment at Cardinal Health I recently joined a diverse group of colleagues in a panel discussion about what it means to be an advocate for gender, racial and...

06/10/2021

Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted...

View all company news »

* Required Fields